The Board of Directors of the company with the corporate name Diagnostic and Therapeutic Centre of Athens HYGEIA Societe Anonyme (hereinafter the Company) hereby informs its main shareholders that the Share Capital Increase by payment in cash with preemptive right in favour of existing shareholders, as decided by the repeat Ordinary General Meeting of the Shareholders of 18 July 2006 and as effected from 30 November 2006 to 14 December 2006, was covered by 61.12% with a payment in cash of a total amount of 5,362,954.57 Euros, which corresponds to 13,080,377 new common registered shares of a nominal value of 0.41 Euros each, while 8,319,623 shares remained unsubscribed. Following the decision of the Company''s Board of Directors of 18 December 2006, the aforementioned unsubscribed shares were made available, on the one hand, to the executives, physicians, personnel and Members of the Board of Directors of the Company and of affiliated companies and, on the other hand, to the Company''s shareholder MARFIN CAPITAL S.A., pursuant to the decision of 18 July 2006 of the Company''s repeat Ordinary General Meeting of the Shareholders, to the report of the Company''s Board of Directors according to article 289 of the regulation of the Athens Stock Exchange and to the Bulletin regarding the Company''s Share Capital Increase. As a result of the above, the Share Capital Increase was fully subscribed and a total amount of 8,774,000 Euros was paid. The issue price of each share had been set at 2.80 Euros, while total revenues from the issue amounted to 59,920,000 Euros. Following the above, the company''s share capital will increase by 8,774,000 Euros with the issuance of 21,400,000 new common registered shares of a nominal value of 0.41 Euros each. The new shares resulting from the aforementioned increase shall be provided to the beneficiaries in dematerialised form by crediting them into their Share and Securities Account with the Dematerialised Securities System. The date as to when the new shares will be credited in the beneficiaries'' accounts and the date as to when the new shares will begin to be traded on the Athens Stock Exchange will be announced upon further notice of the company.